Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

Askar Obulkasim; Bauke Ylstra; Hendrik F. van Essen; Christian Benner; Sally Stenning; Ruth Langley; William Allum; David Cunningham; Imran Inam; Lindsay C. Hewitt; Nicolas P. West; Gerrit A. Meijer; Mark A. van de Wiel; Heike I. Grabsch

doi:10.18632/oncotarget.9857

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

Askar Obulkasim, Bauke Ylstra, Hendrik F. van Essen, Christian Benner, Sally Stenning, Ruth Langley, William Allum, David Cunningham, Imran Inam, Lindsay C. Hewitt, Nicolas P. West, Gerrit A. Meijer, Mark A. van de Wiel, Heike I. Grabsch

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	44084-44095
Journal	Oncotarget
Volume	7
Issue number	28
DOIs	https://doi.org/10.18632/oncotarget.9857
Publication status	Published - 12 Jul 2016

Cite this

Obulkasim, A., Ylstra, B., van Essen, H. F., Benner, C., Stenning, S., Langley, R., ... Grabsch, H. I. (2016). Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget, 7(28), 44084-44095. https://doi.org/10.18632/oncotarget.9857

Obulkasim, Askar ; Ylstra, Bauke ; van Essen, Hendrik F. ; Benner, Christian ; Stenning, Sally ; Langley, Ruth ; Allum, William ; Cunningham, David ; Inam, Imran ; Hewitt, Lindsay C. ; West, Nicolas P. ; Meijer, Gerrit A. ; van de Wiel, Mark A. ; Grabsch, Heike I. / Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. In: Oncotarget. 2016 ; Vol. 7, No. 28. pp. 44084-44095.

@article{3506d4ed312045b39f88549618187fd3,

title = "Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma",

keywords = "esophageal adenocarcinoma, array CGH, prognosis, chemotherapy",

author = "Askar Obulkasim and Bauke Ylstra and {van Essen}, {Hendrik F.} and Christian Benner and Sally Stenning and Ruth Langley and William Allum and David Cunningham and Imran Inam and Hewitt, {Lindsay C.} and West, {Nicolas P.} and Meijer, {Gerrit A.} and {van de Wiel}, {Mark A.} and Grabsch, {Heike I.}",

year = "2016",

month = "7",

day = "12",

doi = "10.18632/oncotarget.9857",

language = "English",

volume = "7",

pages = "44084--44095",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "28",

}

Obulkasim, A, Ylstra, B, van Essen, HF, Benner, C, Stenning, S, Langley, R, Allum, W, Cunningham, D, Inam, I, Hewitt, LC, West, NP, Meijer, GA, van de Wiel, MA & Grabsch, HI 2016, 'Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma', Oncotarget, vol. 7, no. 28, pp. 44084-44095. https://doi.org/10.18632/oncotarget.9857

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. / Obulkasim, Askar; Ylstra, Bauke; van Essen, Hendrik F.; Benner, Christian; Stenning, Sally; Langley, Ruth; Allum, William; Cunningham, David; Inam, Imran; Hewitt, Lindsay C.; West, Nicolas P.; Meijer, Gerrit A.; van de Wiel, Mark A.; Grabsch, Heike I.

In: Oncotarget, Vol. 7, No. 28, 12.07.2016, p. 44084-44095.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

AU - Obulkasim, Askar

AU - Ylstra, Bauke

AU - van Essen, Hendrik F.

AU - Benner, Christian

AU - Stenning, Sally

AU - Langley, Ruth

AU - Allum, William

AU - Cunningham, David

AU - Inam, Imran

AU - Hewitt, Lindsay C.

AU - West, Nicolas P.

AU - Meijer, Gerrit A.

AU - van de Wiel, Mark A.

AU - Grabsch, Heike I.

PY - 2016/7/12

Y1 - 2016/7/12

KW - esophageal adenocarcinoma

KW - array CGH

KW - prognosis

KW - chemotherapy

U2 - 10.18632/oncotarget.9857

DO - 10.18632/oncotarget.9857

M3 - Article

C2 - 27286451

VL - 7

SP - 44084

EP - 44095

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 28

ER -

Access to Document

10.18632/oncotarget.9857